Latest Report on Rett Syndrome Market provides 64 pages with providing 4 company profiles, 10 tables and 21 charts is now available at MarketReportsOnline.com database.

Pune, India -- (SBWire) -- 07/12/2017 --Rett syndrome is a rare genetic neurological disorder. This genetic disorder affects females exclusively due to the presence of X chromosome, and is rarely seen in boys. Male children are less prone to this disorder because boys with mutations in MECP2 hardly survive till birth. Changes in MECP2 typically occur during spermatogenesis, and such changes are usually on the paternal copy of the X-chromosome.

Complete report available at http://www.marketreportsonline.com/600423.html.

The symptoms of Rett syndrome generally occur after 12 months of birth and include signs like slow growth, loss of normal movement and coordination, abnormal hands and eyes movements, and breathing problems. Other drastic symptoms also develop with age. This disorder generally occurs in stages and fourth stage is said to be its last stage. Rett syndrome has no cure and is often treated with off-label drugs which prove to give no relief to the affected patient. Few pharmaceuticals companies are realizing the need for target specific drugs and many therapeutics are being developed, which are in their clinical phases.

Order a copy of this "Rett Syndrome Market" research report at http://www.marketreportsonline.com/contacts/purchase.php?name=600423.

The report "Global Rett Syndrome Market: Industry Analysis & Outlook (2017-2025)" analyzes the development of this market, with focus on Sarizotan drug and its market opportunities. The major players are: Newron Pharmaceuticals, Neurem Pharmaceuticals Limited, Anavex Life Sciences Corp., Neuroloxis, and Edison Pharmaceuticals.

The global Rett syndrome market will grow over the years driven by increase in female population, rising spending on public healthcare programs, and increasing global healthcare expenditure. The major trends and developments of the market include efforts to use gene therapy to rectify this neurological disorder, development of new drugs and use of more efficient technologies. However, growth of the market is challenged by factors like high cost of treatment and high R&D expenditure.

Few Points from List of Charts:

Global Rett Syndrome Prevalence Share by Region (2016)
Global Sarizotan Drug Market Forecast by Value (2018-2025)
Global Sarizotan Drug Market Forecast by Region (2025)
Europe's Rett Syndrome Patient Volume Forecast (2016-2025)
Europe's Rett Syndrome Population with Breathing Disorder (2016-2025)
Europe's Rett Syndrome Patient Diagnosis Rate (2016-2025)
Europe's Sarizotan Drug Market Forecast by Value (2018-2025)
Europe's Sarizotan Drug Treatment by Patient Volume (2018-2025)
The US Rett Syndrome Patient Volume Forecast (2016-2025)
The US Rett Syndrome Population with Breathing Disorder (2016-2025)
The US Rett Syndrome Patient Diagnosis Rate (2016-2025)
The US Sarizotan Drug Market Forecast by Value (2018-2025)
The US Sarizotan Drug Treatment by Patient Volume (2018-2025)
Global Female Population (2012-2016)
Global Spending on Medicines (2010-2020E)

Explore more related reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com